Riskpilot← Back to searchSign inGet full accessNiska Medtech AB
ABActiveOrg 5568871502Rasbo Skeke 30Retail sale of clothing · NACE 4771Est. 20120 employees
Revenue 2024
SEK 143K
EBITDA margin
-203.4%
Equity ratio
5.4%
Financial strength
Net profit 2024
SEK -188K
0 employees
| Revenue | SEK 143K | — |
| EBITDA | SEK -292K | — |
| Net profit | SEK -188K | — |
| Total assets | SEK 1,3M | — |
| Equity | SEK 69K | — |
| Employees | 0 | — |
Legal name
Niska Medtech AB
Org number
5568871502
Legal form
Aktiebolag
NACE code
4771 · Retail sale of clothing
Founded
8 mars 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva ridsportbutik, försäljnings-, grossist- och agenturverksamhet inom medicinteknik och läkemedel samt därmed förenlig verksamhet.
Address
Rasbo Skeke 30
Email
perake.niska1@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 | — | — | — | 143 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | 0 | 0 | 0 | −292 |
| Depreciation & amort. | −41 | — | — | — | −16 |
| EBIT | −49 | 0 | 0 | 0 | −308 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | −49 | 0 | 0 | 0 | −188 |
| Tax | −0 | — | — | — | — |
| Net profit | −49 | — | — | — | −188 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 180 | — | — | — | 1 274 |
| Equity | −344 | — | — | — | 69 |
| Long-term debt | 525 | — | — | — | 1 161 |
| Short-term debt | 0 | — | — | — | 43 |
| Total debt | 525 | — | — | — | 1 204 |
EBITDA margin
-203.4%
This company
15.8%
Market median
-1387% vs market
20202024
Equity ratio
5.4%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
-270.6%
This company
18.4%
Market median
-1571% vs market
20202024
Net profit margin
-130.8%
This company
8.1%
Market median
-1715% vs market
20202024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20202024
Debt / equity
17.37×
This company
0.62×
Market median
-2702% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Niska Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Elisabet Dokken Niska | Deputy Board Member | 0 companies |
| Per-Åke Niska | Chairman | 0 companies |
| Per Emanuel Niska | Board of Directors | 0 companies |